Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma.
Korotchenko E, Schießl V, Scheiblhofer S, Schubert M, Dall E, Joubert IA, Strandt H, Neuper T, Sarajlic M, Bauer R, Geppert M, Joedicke D, Wildner S, Schaller S, Winkler S, Gadermaier G, Horejs-Hoeck J, Weiss R.
Korotchenko E, et al. Among authors: dall e.
Allergy. 2021 Jan;76(1):210-222. doi: 10.1111/all.14481. Epub 2020 Jul 16.
Allergy. 2021.
PMID: 32621318
Free PMC article.